| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06)
|
Bellmunt, Joaquim
|
|
2010
|
11 |
4 |
p. 350-357
8 p.
|
artikel
|
| 2 |
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials
|
Juul, Nicolai
|
|
2010
|
11 |
4 |
p. 358-365
8 p.
|
artikel
|
| 3 |
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
|
Weigelt, Britta
|
|
2010
|
11 |
4 |
p. 339-349
11 p.
|
artikel
|
| 4 |
Broaden the debate about assisted dying
|
The Lancet Oncology,
|
|
2010
|
11 |
4 |
p. 303-
1 p.
|
artikel
|
| 5 |
Cancer charities diversify to weather economic storm
|
Burki, Talha
|
|
2010
|
11 |
4 |
p. 319-
1 p.
|
artikel
|
| 6 |
Celebrities and cancer campaigns: time for a rethink?
|
Holmes, David
|
|
2010
|
11 |
4 |
p. 320-
1 p.
|
artikel
|
| 7 |
Cetuximab in metastatic colorectal cancer
|
Wolf, Ido
|
|
2010
|
11 |
4 |
p. 313-314
2 p.
|
artikel
|
| 8 |
Cetuximab in metastatic colorectal cancer – Author' reply
|
Folprecht, Gunnar
|
|
2010
|
11 |
4 |
p. 314-
1 p.
|
artikel
|
| 9 |
Defining pelvic-radiation disease for the survivorship era
|
Andreyev, H Jervoise N
|
|
2010
|
11 |
4 |
p. 310-312
3 p.
|
artikel
|
| 10 |
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
|
Eriksen, Jesper Grau
|
|
2010
|
11 |
4 |
p. 312-313
2 p.
|
artikel
|
| 11 |
Fine-needle biopsy of metastatic melanoma: clinical use and new applications
|
Murali, Rajmohan
|
|
2010
|
11 |
4 |
p. 391-400
10 p.
|
artikel
|
| 12 |
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study
|
Li, Yafei
|
|
2010
|
11 |
4 |
p. 321-330
10 p.
|
artikel
|
| 13 |
In the interest of full disclosure
|
Burkard, Mark E
|
|
2010
|
11 |
4 |
p. 314-315
2 p.
|
artikel
|
| 14 |
In the interest of full disclosure – Authors' reply
|
Albain, Kathy S
|
|
2010
|
11 |
4 |
p. 315-
1 p.
|
artikel
|
| 15 |
Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial
|
Friedrichs, Birte
|
|
2010
|
11 |
4 |
p. 331-338
8 p.
|
artikel
|
| 16 |
Lung cancer in never smokers: a new hot area of research
|
Govindan, Ramaswamy
|
|
2010
|
11 |
4 |
p. 304-305
2 p.
|
artikel
|
| 17 |
Metronomic chemotherapy for renal cancer in the landscape of targeted therapy
|
Ravaud, Alain
|
|
2010
|
11 |
4 |
p. 307-308
2 p.
|
artikel
|
| 18 |
Molecular epidemiology and its current clinical use in cancer management
|
Hartman, Mikael
|
|
2010
|
11 |
4 |
p. 383-390
8 p.
|
artikel
|
| 19 |
Molecular subtyping of breast cancer: ready to use?
|
de Ronde, Jorma
|
|
2010
|
11 |
4 |
p. 306-307
2 p.
|
artikel
|
| 20 |
New hope for melanoma
|
Pirisi, Angela
|
|
2010
|
11 |
4 |
p. 317-
1 p.
|
artikel
|
| 21 |
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
|
Bayley, Jean-Pierre
|
|
2010
|
11 |
4 |
p. 366-372
7 p.
|
artikel
|
| 22 |
Society of Surgical Oncology annual cancer symposium
|
Brierley, Rob
|
|
2010
|
11 |
4 |
p. 318-
1 p.
|
artikel
|
| 23 |
US Institute of Medicine studies military burn pits
|
Furlow, Bryant
|
|
2010
|
11 |
4 |
p. 316-
1 p.
|
artikel
|
| 24 |
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
|
Bose, Debashish
|
|
2010
|
11 |
4 |
p. 373-382
10 p.
|
artikel
|
| 25 |
Where metabolism meets oncogenesis: another false lead?
|
Grossman, Ashley B
|
|
2010
|
11 |
4 |
p. 309-310
2 p.
|
artikel
|
| 26 |
50 years of allogeneic bone-marrow transplantation
|
Powles, Ray
|
|
2010
|
11 |
4 |
p. 305-306
2 p.
|
artikel
|
Tijdschrift beschrijving